| In vivo amplification of the androgen receptor gene and progression of human prostate cancer T Visakorpi, E Hyytinen, P Koivisto, M Tanner, R Keinänen, C Palmberg, ... Nature genetics 9 (4), 401-406, 1995 | 2004 | 1995 |
| Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer H Joensuu, PL Kellokumpu-Lehtinen, P Bono, T Alanko, V Kataja, ... New England Journal of Medicine 354 (8), 809-820, 2006 | 1932 | 2006 |
| Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors OP Kallioniemi, A Kallioniemi, J Piper, J Isola, FM Waldman, JW Gray, ... Genes, Chromosomes and Cancer 10 (4), 231-243, 1994 | 1220 | 1994 |
| Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer A Ristimäki, A Sivula, J Lundin, M Lundin, T Salminen, C Haglund, ... Cancer research 62 (3), 632-635, 2002 | 1205 | 2002 |
| Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer P Koivisto, J Kononen, C Palmberg, T Tammela, E Hyytinen, J Isola, ... Cancer research 57 (2), 314-319, 1997 | 1023 | 1997 |
| Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab M Tanner, M Hollmen, TT Junttila, AI Kapanen, S Tommola, Y Soini, ... Annals of Oncology 16 (2), 273-278, 2005 | 963 | 2005 |
| Inherited susceptibility to uterine leiomyomas and renal cell cancer V Launonen, O Vierimaa, M Kiuru, J Isola, S Roth, E Pukkala, P Sistonen, ... Proceedings of the National Academy of Sciences 98 (6), 3387-3392, 2001 | 799 | 2001 |
| Trastuzumab emtansine: mechanisms of action and drug resistance M Barok, H Joensuu, J Isola Breast cancer research 16, 1-12, 2014 | 676 | 2014 |
| Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line P Nagy, E Friedländer, M Tanner, AI Kapanen, KL Carraway, J Isola, ... Cancer research 65 (2), 473-482, 2005 | 663 | 2005 |
| Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity LH Saal, P Johansson, K Holm, SK Gruvberger-Saal, QB She, M Maurer, ... Proceedings of the National Academy of Sciences 104 (18), 7564-7569, 2007 | 642 | 2007 |
| Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization T Visakorpi, AH Kallioniemi, AC Syvänen, ER Hyytinen, R Karhu, ... Cancer research 55 (2), 342-347, 1995 | 627 | 1995 |
| Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the … H Joensuu, P Bono, V Kataja, T Alanko, R Kokko, R Asola, T Utriainen, ... Journal of Clinical Oncology 27 (34), 5685-5692, 2009 | 602 | 2009 |
| ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 VJ Tuominen, S Ruotoistenmäki, A Viitanen, M Jumppanen, J Isola Breast cancer research 12, 1-12, 2010 | 593 | 2010 |
| Amplification and deletion of topoisomerase IIα associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer TAH Järvinen, M Tanner, V Rantanen, M Bärlund, Å Borg, S Grénman, ... The American journal of pathology 156 (3), 839-847, 2000 | 529 | 2000 |
| Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples M Tanner, D Gancberg, A Di Leo, D Larsimont, G Rouas, MJ Piccart, ... The American journal of pathology 157 (5), 1467-1472, 2000 | 504 | 2000 |
| Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer T Kuukasjärvi, R Karhu, M Tanner, M Kähkönen, A Schäffer, N Nupponen, ... Cancer research 57 (8), 1597-1604, 1997 | 503 | 1997 |
| Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. J Isola, S DeVries, L Chu, S Ghazvini, F Waldman The American journal of pathology 145 (6), 1301, 1994 | 500 | 1994 |
| Distinct Somatic Genetic Changes Associated with Tumor Progression in Carriers of BRCA1 and BRCA2 Germ-line Mutations M Tirkkonen, O Johannsson, BA Agnarsson, H Olsson, S Ingvarsson, ... Cancer research 57 (7), 1222-1227, 1997 | 487 | 1997 |
| Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients J Isola, T Visakorpi, K Holli, OP Kallioniemi JNCI: Journal of the National Cancer Institute 84 (14), 1109-1114, 1992 | 456 | 1992 |
| Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. T Kuukasjärvi, J Kononen, H Helin, K Holli, J Isola Journal of Clinical Oncology 14 (9), 2584-2589, 1996 | 447 | 1996 |
